Shares of Gilead Sciences (NASDAQ: GILD) gained 11.9% over the course of January, according to data from S&P Global Market Intelligence. Why were investors piling into this top biotech stock last month?
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,